Clinical Cancer Drugs

Limited Time Complementary OA Offer Papers submitted on or before December 31, 2023, will be published as Promotional Open Access

ISSN (Print): 2212-697X
ISSN (Online): 2212-6988

This journal supports open access

Back Journal Home

Institutional Members
Topic(s) Covered

1 Topic(s)

View
Covered Disease(s)

1 Disease(s)

View

Aims & Scope

Clinical Cancer Drugs publishes original research and (as well as) expert reviews, and thematic issues in all core areas of translational and clinical cancer drug research.

The journal publishes pre-clinical and clinical studies on the development of new anti-cancer agents. Clinical studies of new reported anti-cancer drugs include Phase 1–IV clinical trial studies, their designs, research methodologies, and analyses. The journal is essential reading to clinical oncologists, toxicologists, medicinal chemists, and to pharmacologists.

Announcement for Authors

Get Free Open Access by submitting your article by or before December 31, 2023.

Click here to submit your paper now!

Special Offers

30% discount on the single-issue cost to authors on the purchase of issue(s) in which their article is published.
Multiple issue copies at discounted rates.

Archived in
Announcements
© 2025 Bentham Science Publishers | Privacy Policy